🇺🇸
United States · US · US:0409-5086_b4cff5d5-d1ec-4959-b062-e754517aab2d
TAZICEF
In shortageOrange BookUNIISPLATC J01DD02
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerHospira, Inc.
CountryUS (United States)
ATC codeJ01DD02
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc11040950861110 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (0409-5086-11) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PHARMACY BULK PACKAGE (0409-5086-13)
Annotations
UNII (FDA Substance ID)
9M416Z9QNR
CEFTAZIDIME
RxCUI 235552
Orange Book
A062662
APAPAP
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Ceftazidime Injection
Raw payload (JSON)
{
"unii": {
"unii": "9M416Z9QNR",
"rxcui": "235552",
"inchikey": "NMVPEQXCMGEDNH-TZVUEUGBSA-N",
"display_name": "CEFTAZIDIME",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"40d48c5d-650e-461b-a67b-7e65772d1b92": {
"match": "brand_token",
"title": "TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]",
"spl_version": "16",
"published_date": "2026-05-13"
}
},
"productid": "0409-5086_b4cff5d5-d1ec-4959-b062-e754517aab2d",
"productndc": "0409-5086",
"dosage_form": "INJECTION, POWDER, FOR SOLUTION",
"orange_book": {
"appl_no": "062662",
"products": [
{
"rs": false,
"rld": false,
"te_code": null,
"strength": "500MG/VIAL",
"product_no": "001",
"approval_date": "Mar 6, 1986"
},
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "1GM/VIAL",
"product_no": "002",
"approval_date": "Mar 6, 1986"
},
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "2GM/VIAL",
"product_no": "003",
"approval_date": "Mar 6, 1986"
},
{
"rs": false,
"rld": false,
"te_code": "AP",
"strength": "6GM/VIAL",
"product_no": "004",
"approval_date": "Mar 6, 1986"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "CEFTAZIDIME",
"shortage_reason": "Ceftazidime Injection",
"shortage_status": "current",
"proprietary_name": "TAZICEF",
"active_ingred_unit": "g/1",
"application_number": "ANDA062662",
"marketing_category": "ANDA",
"nonproprietary_name": "CEFTAZIDIME",
"start_marketing_date": "20060420",
"active_numerator_strength": "6"
}Related drugs
Other records sharing ATC code J01DD02.
- CZALTECIMMedochemie Ltd., Limassol
- CZALTECIMMedochemie Ltd., Limassol
- CZALTECIMMedochemie Ltd., Limassol
- CZALTECIMMedochemie Ltd., Limassol
- NLAltecim 2 g poeder voor oplossing voor injectie/infusieMedochemie Limited
- NLAltecim 1 g poeder voor oplossing voor injectie/infusieMedochemie Limited
- PLBiotumZakłady Farmaceutyczne POLPHARMA S.A.
- PLBiotumZakłady Farmaceutyczne POLPHARMA S.A.
Access this data programmatically
Query TAZICEF and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.